Forbes: Teen’s ‘Stomach Ache’ Was Stage 3 Ovarian Cancer. Read Her Journey Story of Maya Ortiz who was diagnosed with Stage 3 Ovarian Cancer at age 18. Experts weigh in on how this disease presents, is diagnosed, and managed.

Context Explanation

A newly identified interaction between ovarian cancer cells and surrounding abdominal cells helps explain the cancer’s unusually fast and aggressive spread. Medical Xpress on MSN: A redesigned endoscope offers a new way to look for early signs of ovarian cancer Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, and existing screening approaches—such as blood tests and transvaginal ... A redesigned endoscope offers a new way to look for early signs of ovarian cancer SurvivorNet on MSN: Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse The FDA has approved Lifyorli (relacorilant) plus Abraxane for certain platinum‑resistant ovarian cancer patients, offering a new option after prior treatments stop working.

Insight Material

Newly approved ovarian cancer treatment combination with the drug Lifyorli helps give time after relapse AOL: AI-powered electronic nose can 'smell' early signs of ovarian cancer in the blood AI-powered electronic nose can 'smell' early signs of ovarian cancer in the blood Nancy Long was a gynecological nurse practitioner when she was diagnosed with ovarian cancer. Yet because the symptoms were so vague, she nearly ignored them. “I missed all the signs and symptoms of ... Targeted Oncology: FDA Grants Fast Track Designation to ADC for Platinum-Resistant Ovarian Cancer The FDA has granted Fast Track designation to the investigational antibody-drug conjugate (ADC) SIM0505 for the treatment of women with platinum-resistant ovarian cancer. The designation adds SIM0505 ...

Final Conclusion